Neoleukin Therapeutics
Seattle, WA
Neoleukin Therapeutics emerged from the University of Washington Institute for Protein Design in January of 2019. We are creating next generation immunotherapies using breakthrough de novo protein design technology. We use natural protein complexes as inspiration to develop custom designed proteins with superior pharmaceutical properties.
neoleukin.comCompany Details
Founded
- 2019
Employees
- Between 20 - 100 employees
Raised
- $157,600,000
Headquarters Location
- Seattle, WA
Public
- Yes
Acquired
- Yes
CEO
Donna Cochener
Founders
- Jonathan Drachman
Company Collections
These are collections Neoleukin Therapeutics is a part of. Click on the collection name to view similar companies.